What is Bipolar Androgen Therapy

Understanding Bipolar Androgen Therapy (BAT)

What It Is

Bipolar Androgen Therapy is a treatment approach for advanced prostate cancer that works by cycling testosterone levels up and down in a controlled way. The name "bipolar" refers to these two opposite states—high testosterone followed by low testosterone.

Here's how it works:

The Cycling Pattern:

• High phase: Patients receive injections of testosterone (typically 400 mg of testosterone cypionate once monthly), raising levels to supraphysiological (much higher than the body normally produces—above 1,500 ng/dL)
• Low phase: Patients receive androgen deprivation therapy (ADT), which blocks testosterone production, dropping levels to very low (below 150 ng/dL)

This cycle repeats, essentially "toggling" testosterone on and off.

Why This Approach?

The reasoning is counterintuitive: prostate cancer cells that have adapted to survive without testosterone become vulnerable when suddenly exposed to high testosterone levels. Researchers have treated over 400 patients in clinical studies since 2013, according to work by Dr. [removed] Antonarakis and colleagues at Johns Hopkins.

Important Context: When BAT Is Used

BAT is NOT recommended for newly diagnosed prostate cancer. According to the clinical experience documented in the CancerPatientLab webinars, BAT should only be considered for patients with castration-resistant prostate cancer—meaning their cancer has progressed despite standard hormone-blocking therapy. Using BAT in hormone-sensitive disease (early-stage cancer still responding to standard treatment) can actually make the cancer worse.

How Patients Typically Respond

Research shows responses fall into roughly three equal groups:

• 1/3 of patients: Show significant PSA reduction and cancer shrinkage
• 1/3 of patients: Experience disease stabilization (cancer stops growing, quality of life may improve)
• 1/3 of patients: See no benefit or disease progression

This means approximately 2 out of 3 patients experience some benefit (either improvement or stabilization).

Important Monitoring Considerations

One key lesson from clinical experience: Don't panic if PSA rises initially. According to Dr. [removed] research, PSA often increases in the first 1-2 cycles before declining. In one early patient, PSA rose from 22 to 37 before eventually dropping, and a large pelvic mass visible on imaging eventually disappeared.

Similarly, bone scans may temporarily look worse before improving—a phenomenon called "bone scan flare"—even as PSA is dropping.

Quality of Life Aspect

An interesting finding: Some patients report improved sexual function and energy during BAT compared to continuous hormone-blocking therapy, since testosterone levels cycle back up periodically.

---

Questions to Ask Your Oncologist

If your doctor mentions BAT as a possibility:

1. "Is my cancer castration-resistant, and have I exhausted standard hormone therapies?" (This determines if BAT is appropriate timing)
2. "What monitoring will you use to assess my response—PSA, scans, or both?" (Understanding how they'll track effectiveness)
3. "What should I expect if my PSA rises in the first few cycles?" (Preparing for the counterintuitive initial response)
4. "Are there any genetic tests (like BRCA or DNA repair mutations) that might predict how I'd respond?" (Some evidence suggests certain mutations may predict better response)
5. "What's your experience with BAT, and how many patients have you treated?" (Experience matters with this less common approach)

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources Cited:

• CancerPatientLab Webinars: "Bipolar Androgen Therapy for Prostate Cancer" (Emmanuel Antonarakis, MD)
• CancerPatientLab Webinars: "Bipolar Androgen Therapy" (Bryce Olson and Bob Gatenby, MD)